DR. RANDOLPH'S
LIVE

Serial Number

98433697

Owner

Cleveland W. Randolph, Jr., M.D., P.A.

Attorney

James R Menker

First Use Date

Dec 31, 2007

Filing Date

Mar 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

DR. RANDOLPH'S Trademark

Serial Number: 98433697

DR. RANDOLPH'S is a trademark filed by Cleveland W. Randolph, Jr., M.D., P.A. on March 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Cleveland W. Randolph, Jr., M.D., P.A.

1891 Beach Blvd., Suite 200
Jacksonville Beach, FL 32250

Entity Type: 03

Trademark Details

Filing Date

March 5, 2024

Registration Date

Not Registered

First Use Anywhere

December 31, 2007

First Use in Commerce

December 31, 2007

Published for Opposition

June 30, 2026

Goods & Services

Vitamins and vitamin preparations; Vitamin supplements; Nutritional supplements; Dietary supplements; Probiotic supplements; Bio-identical hormone replacement therapy preparations; Nutraceuticals for the treatment of conditions associated with andropause; Nutraceuticals for the treatment of conditions associated with menopause; Nutraceuticals for the treatment of conditions associated with pre-menopause and peri-menopause; Nutraceuticals for improving bone health; Nutraceuticals for improving brain health; Nutraceuticals for improving digestive health; Nutraceuticals for improving gastrointestinal health; Nutraceuticals for improving sexual vitality; Nutraceuticals for improving sleep, stress and mood; Nutraceutical preparations for reducing stress and fatigue; Nutraceuticals used to aid in sleep and relaxation; Medicated creams for treating hormone imbalance; Medicated creams to aid in sleep and relaxation; Dietary and nutritional supplements used for weight loss; Nutraceuticals for hepatic support; Nutraceuticals for boosting the immune system and intended to provide immune system support; Nutraceuticals for detox; all of the foregoing being for human consumption

Retail store services and online retail store services featuring vitamins, supplements, nutraceuticals, men's health products, women's health products, sleep and relaxation products, hormone balance preparations, bio-identical hormone replacement therapies, anti-aging preparations, all for human consumption and health and wellness books

Medical services; Wellness and health-related consulting services; Conducting telephone and in-person personal lifestyle wellness assessments; Pharmaceutical compounding services; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, anti-aging therapy, sexual vitality therapy and natural hormone therapy; Gynecology services

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 1, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 1, 2026 CRFA
ASSIGNED TO LIE
Jun 1, 2026 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 28, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 13, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 13, 2026 GNSL
SUSPENSION LETTER WRITTEN
Feb 13, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 12, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 12, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 2, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 2, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 2, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 19, 2025 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 4, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 24, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 24, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 24, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2024 NWOS
NEW APPLICATION ENTERED
Mar 8, 2024 NWAP